請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/58126完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 張煥正(Huan-Cheng Chang) | |
| dc.contributor.author | Tzu-Wei Huang | en |
| dc.contributor.author | 黃紫葳 | zh_TW |
| dc.date.accessioned | 2021-06-16T08:06:27Z | - |
| dc.date.available | 2017-07-04 | |
| dc.date.copyright | 2014-07-04 | |
| dc.date.issued | 2014 | |
| dc.date.submitted | 2014-06-19 | |
| dc.identifier.citation | 1. Reya, T.; Morrison, S. J.; Clarke, M. F.; Weissman, I. L., Stem cells, cancer, and cancer stem cells. Nature 2001, 414 (6859), 105-111.
2. Lobo, N. A.; Shimono, Y.; Qian, D.; Clarke, M. F., The biology of cancer stem cells. Annu. Rev. Cell Dev. Biol. 2007, 23, 675-699. 3. Heppner, G. H., Tumor heterogeneity. Cancer research 1984, 44 (6), 2259-2265. 4. Fidler, I. J.; Hart, I. R., Biological diversity in metastatic neoplasms: origins and implications. Science 1982, 217 (4564), 998-1003. 5. Visvader, J. E.; Lindeman, G. J., Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nature Reviews Cancer 2008, 8 (10), 755-768. 6. Al-Hajj, M.; Wicha, M. S.; Benito-Hernandez, A.; Morrison, S. J.; Clarke, M. F., Prospective identification of tumorigenic breast cancer cells. Proceedings of the National Academy of Sciences 2003, 100 (7), 3983-3988. 7. Lapidot, T.; Sirard, C.; Vormoor, J.; Murdoch, B.; Hoang, T.; Caceres-Cortes, J.; Minden, M.; Paterson, B.; Caligiuri, M.; Dick, J., A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 1994, 367 (6464), 645-648. 8. Bao, S.; Wu, Q.; McLendon, R. E.; Hao, Y.; Shi, Q.; Hjelmeland, A. B.; Dewhirst, M. W.; Bigner, D. D.; Rich, J. N., Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006, 444 (7120), 756-760. 9. Rich, J. N.; Eyler, C. E., Cancer stem cells in brain tumor biology. Cold Spring Harbor symposia on quantitative biology 2008, 73, 411-420. 10. Li, C.; Heidt, D. G.; Dalerba, P.; Burant, C. F.; Zhang, L.; Adsay, V.; Wicha, M.; Clarke, M. F.; Simeone, D. M., Identification of pancreatic cancer stem cells. Cancer research 2007, 67 (3), 1030-1037. 11. Dalerba, P.; Dylla, S. J.; Park, I.-K.; Liu, R.; Wang, X.; Cho, R. W.; Hoey, T.; Gurney, A.; Huang, E. H.; Simeone, D. M., Phenotypic characterization of human colorectal cancer stem cells. Proceedings of the National Academy of Sciences 2007, 104 (24), 10158-10163. 12. Gilbertson, R. J.; Graham, T. A., Cancer: Resolving the stem-cell debate. Nature 2012, 488 (7412), 462-463. 13. Chudakov, D. M.; Lukyanov, S.; Lukyanov, K. A., Fluorescent proteins as a toolkit for in vivo imaging. Trends in Biotechnology 2005, 23 (12), 605-613. 14. Köhler, R. H.; Zipfel, W. R.; Webb, W. W.; Hanson, M. R., The green fluorescent protein as a marker to visualize plant mitochondria in vivo. The Plant Journal 1997, 11 (3), 613-621. 15. Games, D.; Adams, D.; Alessandrini, R.; Barbour, R.; Berthelette, P.; Blackwell, C.; Carr, T.; Clemens, J.; Donaldson, T.; Gillespie, F., Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature 1995, 373 (6514), 523-527. 16. Cobelli, C.; Toffolo, G.; Foster, D. M., Tracer-to-tracee ratio for analysis of stable isotope tracer data: link with radioactive kinetic formalism. American Journal of Physiology-Endocrinology And Metabolism 1992, 262 (6), E968-E975. 17. Thorne, S. H., Strategies to achieve systemic delivery of therapeutic cells and microbes to tumors. Expert Opinion on Biological Therapy 2007, 7(1), 41-51.. 18. Hong, H.; Yang, Y.; Zhang, Y.; Cai, W., Non-invasive cell tracking in cancer and cancer therapy. Current topics in medicinal chemistry 2010, 10 (12), 1237-1248. 19. Hoffman, R. M., Green fluorescent protein imaging of tumour growth, metastasis, and angiogenesis in mouse models. The lancet oncology 2002, 3 (9), 546-556. 20. Folkman, J., Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature medicine 1995, 1 (1), 27-30. 21. Jaffe, N., Recent advances in the chemotherapy of metastatic osteogenic sarcoma. Cancer 1972, 30 (6), 1627-1631. 22. Hoffman, R. M., In vivo imaging with fluorescent proteins: the new cell biology. Acta Histochemica 2004, 106 (2), 77-87. 23. Hoffman, R. M., Advantages of multi-color fluorescent proteins for whole-body and in vivo cellular imaging. Journal of biomedical optics 2005, 10 (4), 041202-041202-10. 24. Parish, C. R., Fluorescent dyes for lymphocyte migration and proliferation studies. Immunology and cell biology 1999, 77 (6), 499-508. 25. Lyons, A. B., Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution. Journal of immunological methods 2000, 243 (1), 147-154. 26. Von Hörsten, S.; Helfritz, A.; Kuhlmann, S.; Nave, H.; Tschernig, T.; Pabst, R.; Ben-Eliyahu, S.; Meyer, D.; Schmidt, R. E.; Schmitz, C., Stereological quantification of carboxyfluorescein-labeled rat lung metastasis: a new method for the assessment of natural killer cell activity and tumor adhesion in vivo and in situ. Journal of immunological methods 2000, 239 (1), 25-34. 27. Cappella, P.; Gasparri, F.; Pulici, M.; Moll, J., A novel method based on click chemistry, which overcomes limitations of cell cycle analysis by classical determination of BrdU incorporation, allowing multiplex antibody staining. Cytometry Part A 2008, 73 (7), 626-636. 28. Waldman, F.; Chew, K.; Ljung, B.; Goodson, W.; Hom, J.; Duarte, L.; Smith, H.; Mayall, B., A comparison between bromodeoxyuridine and 3H thymidine labeling in human breast tumors. Modern pathology: an official journal of the United States and Canadian Academy of Pathology, Inc 1991, 4 (6), 718-722. 29. Gratzner, H. G., Monoclonal antibody to 5-bromo-and 5-iododeoxyuridine: a new reagent for detection of DNA replication. Science 1982, 218 (4571), 474-475. 30. Salic, A.; Mitchison, T. J., A chemical method for fast and sensitive detection of DNA synthesis in vivo. Proceedings of the National Academy of Sciences 2008, 105 (7), 2415-2420. 31. Lippincott-Schwartz, J.; Altan-Bonnet, N.; Patterson, G. H., Photobleaching and photoactivation: following protein dynamics in living cells. Nature cell biology. 2003, S7-S14. 32. Michalet, X.; Pinaud, F. F.; Bentolila, L. A.; Tsay, J. M.; Doose, S.; Li, J. J.; Sundaresan, G.; Wu, A. M.; Gambhir, S. S.; Weiss, S., Quantum dots for live cells, in vivo imaging, and diagnostics. Science 2005, 307 (5709), 538-544. 33. Wu, X.; Liu, H.; Liu, J.; Haley, K. N.; Treadway, J. A.; Larson, J. P.; Ge, N.; Peale, F.; Bruchez, M. P., Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots. Nature biotechnology. 2003, 21 (1), 41-46. 34. Dabbousi, B. O.; Rodriguez-Viejo, J.; Mikulec, F. V.; Heine, J. R.; Mattoussi, H.; Ober, R.; Jensen, K. F.; Bawendi, M. G., (CdSe)ZnS core-shell quantum dots: Synthesis and characterization of a size series of highly luminescent nanocrystallites. J. Phys. Chem. B 1997, 101 (46), 9463-9475. 35. Månsson, A.; Sundberg, M.; Balaz, M.; Bunk, R.; Nicholls, I. A.; Omling, P.; Tågerud, S.; Montelius, L., In vitro sliding of actin filaments labelled with single quantum dots. Biochem. Biophys. Res. Commun. 2004, 314 (2), 529-534. 36. Su, Y. Y.; He, Y.; Lu, H. T.; Sai, L. M.; Li, Q. N.; Li, W. X.; Wang, L. H.; Shen, P. P.; Huang, Q.; Fan, C. H., The cytotoxicity of cadmium based, aqueous phase - Synthesized, quantum dots and its modulation by surface coating. Biomaterials 2009, 30 (1), 19-25. 37. Maysinger, D.; Behrendt, M.; Lalancette-Hébert, M.; Kriz, J., Real-time imaging of astrocyte response to quantum dots: in vivo screening model system for biocompatibility of nanoparticles. Nano Lett. 2007, 7 (8), 2513-2520. 38. Sokolov, K.; Follen, M.; Aaron, J.; Pavlova, I.; Malpica, A.; Lotan, R.; Richards-Kortum, R., Real-time vital optical imaging of precancer using anti-epidermal growth factor receptor antibodies conjugated to gold nanoparticles. Cancer research. 2003, 63 (9), 1999-2004. 39. Schrand, A. M.; Huang, H.; Carlson, C.; Schlager, J. J.; Omacr Sawa, E.; Hussain, S. M.; Dai, L., Are diamond nanoparticles cytotoxic? J. Phys. Chem. B 2007, 111 (1), 2-7. 40. Schrand, A. M.; Dai, L.; Schlager, J. J.; Hussain, S. M.; Osawa, E., Differential biocompatibility of carbon nanotubes and nanodiamonds. Diamond and Related Materials 2007, 16 (12), 2118-2123. 41. Weissleder, R.; Ntziachristos, V., Shedding light onto live molecular targets. Nature medicine 2003, 9 (1), 123-128. 42. Fang, C. Y.; Vaijayanthimala, V.; Cheng, C. A.; Yeh, S. H.; Chang, C. F.; Li, C. L.; Chang, H. C., The Exocytosis of Fluorescent Nanodiamond and Its Use as a Long‐Term Cell Tracker. Small 2011, 7 (23), 3363-3370. 43. Liu, K.-K.; Wang, C.-C.; Cheng, C.-L.; Chao, J.-I., Endocytic carboxylated nanodiamond for the labeling and tracking of cell division and differentiation in cancer and stem cells. Biomaterials 2009, 30 (26), 4249-4259. 44. Vaijayanthimala, V.; Tzeng, Y.-K.; Chang, H.-C.; Li, C.-L., The biocompatibility of fluorescent nanodiamonds and their mechanism of cellular uptake. Nanotechnology 2009, 20 (42), 425103-425103. 45. Kondo, K. i.; Ahrens, T. J., Shock compression of diamond crystal. Geophysical Research Letters 1983, 10 (4), 281-284. 46. Davies, G., Properties and growth of diamond. INSPEC, the Institution of Electrical Engineers 1994. 47. Walker, J., Optical absorption and luminescence in diamond. Reports on progress in physics 1979, 42 (10), 1605-1659. 48. Koscheev, A.; Gromov, M.; Mohapatra, R.; Ott, U., History of trace gases in presolar diamonds inferred from ion-implantation experiments. Nature 2001, 412 (6847), 615-617. 49. Lawson, S. C.; Fisher, D.; Hunt, D. C.; Newton, M. E., On the existence of positively charged single-substitutional nitrogen in diamond. Journal of Physics: Condensed Matter 1998, 10 (27), 6171-6180. 50. Davies, G.; Hamer, M., Optical studies of the 1.945 eV vibronic band in diamond. Proceedings of the Royal Society of London. A. Mathematical and Physical Sciences 1976, 348 (1653), 285-298. 51. Jones, R.; Goss, J., Theory of aggregation of nitrogen in diamond. EMIS DATAREVIEWS SERIES 2002, 26, 127-129. 52. Fu, C.-C.; Lee, H.-Y.; Chen, K.; Lim, T.-S.; Wu, H.-Y.; Lin, P.-K.; Wei, P.-K.; Tsao, P.-H.; Chang, H.-C.; Fann, W., Characterization and application of single fluorescent nanodiamonds as cellular biomarkers. Proceedings of the National Academy of Sciences 2007, 104 (3), 727-732. 53. Nguyen, T.; Chang, H.-C.; Wu, V. W.-K., Adsorption and hydrolytic activity of lysozyme on diamond nanocrystallites. Diamond and related materials 2007, 16 (4), 872-876. 54. Yu, S.-J.; Kang, M.-W.; Chang, H.-C.; Chen, K.-M.; Yu, Y.-C., Bright fluorescent nanodiamonds: no photobleaching and low cytotoxicity. Journal of the American Chemical Society 2005, 127 (50), 17604-17605. 55. Schrand, A. M.; Huang, H.; Carlson, C.; Schlager, J. J.; Osawa, E.; Hussain, S. M.; Dai, L., Are diamond nanoparticles cytotoxic? The Journal of Physical Chemistry B 2007, 111 (1), 2-7. 56. Kieran O Neill ; Nima Aghaeepour ; Josef Spidlen; Brinkman, R., Flow Cytometry Bioinformatics PLOS Computational Biology 2013, 9 (12), e1003365. 57. Cai, R.; Hashimoto, K.; Itoh, K.; Kubota, Y.; Fujishima, A., Photokilling of malignant cells with ultrafine TiO2 powder. Bulletin of the Chemical Society of Japan 1991, 64 (4), 1268-1273. 58. Sayes, C. M.; Wahi, R.; Kurian, P. A.; Liu, Y.; West, J. L.; Ausman, K. D.; Warheit, D. B.; Colvin, V. L., Correlating nanoscale titania structure with toxicity: a cytotoxicity and inflammatory response study with human dermal fibroblasts and human lung epithelial cells. Toxicological Sciences 2006, 92 (1), 174-185. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/58126 | - |
| dc.description.abstract | 腫瘤是由非勻相細胞所組成,其中有一群特定的腫瘤細胞具有類似幹細胞自我更新及不斷的增生出子代癌細胞的能力,即為癌症幹細胞(cancer stem cells;CSCs)。此群細胞被認為在癌症的形成、癌症復發及轉移、抗藥性有密不可分的關係。因此如何以螢光標記物標記追蹤此群癌症幹細胞成為重要的研究課題。
而螢光染料用於細胞標記雖具強螢光強度且標記專一等優點,然而螢光容易消失,而有著一定限制。而螢光奈米鑽石不僅有高生物相容性且有穩定的螢光性,克服了螢光染料不利於長時間的追蹤的缺點,因此設計了一新穎的策略來標記追蹤癌症幹細胞。 本論文中結合螢光奈米鑽石和乳癌細胞,利用螢光奈米鑽石的螢光判斷細胞的分化狀況、和觀察非黏附性乳腺球細胞(mammosphere)的成長,並和常用的細胞追蹤螢光染料CFSE (carboxyfluorescentsuccinimidy ester)及EdU (5-ethynyl-2-deoxyuridine)做比較。實驗一開始先由非黏附性乳腺球的重新生長實驗證實癌症幹細胞具自我更新能力,並以共軛焦顯微鏡和流式細胞儀觀察,發現在第二代的非黏附性乳腺球細胞中仍然可偵測到螢光奈米鑽石之螢光,而CFSE和EdU標記的細胞則無螢光維持。而由細胞追蹤20天實驗當中,比較三種螢光標記物追蹤具有癌症幹細胞特性之細胞的能力,結果顯示20天後螢光奈米鑽石相較於CFSE及EdU,可維持在非黏附性乳腺球細胞中有較高的螢光強度,表示螢光奈米鑽石在此實驗策略中是為長時間追蹤癌症幹細胞群的有利工具。 | zh_TW |
| dc.description.abstract | Cells within tumor population exhibit functional and phenotypic heterogeneities, and there exists a minor population of tumor cells, termed cancer stem cells (CSCs), having the capacity of self-renewal and differentiation. These CSCs are thought to drive tumor growth, tumor recurrence, drug resistance and metastasis. Therefore, how to use markers to label and track CSCs has been an important issue in biomedical research. Although organic dyes have been commonly used for cell labeling due to their advantages of strong fluorescence emission and easiness of conjugation with biomolecules, but there are some restrictions, such as photobleaching, which prevent long-term observations. This problem can be readily overcome by using fluorescent nanodiamonds (FNDs), which have not only high biocompatibility but also excellent photostability. Here, we proposed to use the FND labeling method to investigate the cell differentiation and growth of primary mammospheres, with the results to be compared with those of the fluorescent markers, CFSE (carboxyfluorescentsuccinimidy ester) and EdU (5-ethynyl-2-deoxyuridine).
The formation of primary mammospheres is a measure of stem cell activity, and thus cannot be used to assess stem cell self-renewal. However, primary mammospheres can be harvested, digested to single cells, and passaged for the assessment of their self-renewal (secondary generation). In this study, we found that mammospheres derived from ASB-145-1R cells can be passaged to satisfy the true criteria of self-renewal. The fluorescence of FND, but not of CFSE and EdU, can be detected in the second generation of the mammospheres by using confocal microscopy and flow cytometry. Results of long-term labeling and tracking of breast CSCs show that the number of cells retaining FNDs in the mammospheres is higher than those of CFSE- and EdU-labeled cells. It is concluded that the FND labeling is a valuable and effective tool for long-term tracking of CSCs. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-16T08:06:27Z (GMT). No. of bitstreams: 1 ntu-103-R01223154-1.pdf: 4383248 bytes, checksum: 992ac9c6643cb0650127bbfac80f40f6 (MD5) Previous issue date: 2014 | en |
| dc.description.tableofcontents | 口試委員會審定書 #
中文摘要 i Abstract iii 目錄 v 圖目錄 viii 表目錄 x 第一章 緒論 1 1.1 前言 1 1.2 癌症幹細胞 1 1.2.1 幹細胞 1 1.2.2 癌症幹細胞特性 2 1.3 細胞標記(cell labeling)及細胞追蹤(cell tracking) 4 1.4 細胞追蹤應用 4 1.4.1 5-Ethynyl-2′-deoxyuridine (EdU) 6 1.4.2 Carboxyfluorescein diacetate succinimidyl ester (CFDASE, CFSE) 7 1.4.3 奈米材料應用於細胞標記 8 1.5 螢光奈米鑽石 12 1.5.1 鑽石的結構 12 1.5.2 鑽石的種類 13 1.5.3 螢光奈米鑽石的缺陷中心 14 1.5.4 螢光奈米鑽石的特性 15 1.6 研究動機 16 第二章 實驗儀器裝置與藥品 17 2.1 實驗儀器 17 2.1.1 氦離子束佈值裝置 18 2.1.2 流式細胞儀 20 2.2 實驗藥品 22 第三章 實驗步驟 24 3.1 製備粒徑為100奈米的螢光奈米鑽石 24 3.1.1 奈米鑽石的佈值前處理 24 3.1.2 離子束佈值 25 3.1.3 高溫淬火 26 3.2 利用螢光奈米鑽石追蹤乳腺癌幹細胞 27 3.2.1 乳癌癌症幹細胞來源 27 3.2.2 乳癌癌症細胞培養 27 3.2.3 非黏附性乳腺球(mammosphere)形成 27 3.2.4 EdU標記乳癌細胞 28 3.2.5 螢光奈米鑽石標記乳癌細胞 28 3.2.6 CFSE染色 28 3.2.7 非黏附性乳腺球細胞膜染色 28 3.2.8 非黏附性乳腺球分離成單顆細胞 29 3.2.9 實驗流程 29 第四章 實驗結果 30 4.1 非黏附性乳腺球重新生長(Mammosphere re-growth) 30 4.1.1 使用顯微鏡觀察非黏附性乳腺球大小、數量 31 4.1.2 用流式細胞儀測螢光強度 35 4.1.3 用共軛焦顯微鏡拍攝非黏附性乳腺球 38 4.2 乳癌幹細胞的20天長時間追蹤 40 第五章 結論 45 參考資料 46 | |
| dc.language.iso | zh-TW | |
| dc.subject | 細胞標記 | zh_TW |
| dc.subject | 乳腺癌幹細胞 | zh_TW |
| dc.subject | 螢光奈米鑽石 | zh_TW |
| dc.subject | Fluorescent nanodiamond (FND) | en |
| dc.subject | Cancer stem cell (CSC) | en |
| dc.subject | Cell tracking | en |
| dc.title | 以螢光奈米鑽石標記與追蹤人類癌症幹細胞 | zh_TW |
| dc.title | Fluorescent Nanodiamonds for Labeling and Tracking
Human Cancer Stem Cells | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 102-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.coadvisor | 陳逸聰(Yit-Tsong Chen) | |
| dc.contributor.oralexamcommittee | 吳志哲(Chih-Che Wu) | |
| dc.subject.keyword | 螢光奈米鑽石,乳腺癌幹細胞,細胞標記, | zh_TW |
| dc.subject.keyword | Fluorescent nanodiamond (FND),Cancer stem cell (CSC),Cell tracking, | en |
| dc.relation.page | 49 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2014-06-19 | |
| dc.contributor.author-college | 理學院 | zh_TW |
| dc.contributor.author-dept | 化學研究所 | zh_TW |
| 顯示於系所單位: | 化學系 | |
文件中的檔案:
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-103-1.pdf 未授權公開取用 | 4.28 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。
